Is AtriCure, Inc. (ATRC) Halal?

NASDAQ Healthcare United States $1.4B
✓ HALAL
Confidence: 95/100
AtriCure, Inc. (ATRC) is Halal under all 5 major Shariah screening standards. With a debt ratio of just 4.9% against the AAOIFI threshold of 30%, AtriCure, Inc. comfortably passes the key financial ratio tests. The company operates in the Healthcare sector (Medical Instruments & Supplies), which is not a prohibited industry under Islamic finance principles.

Shariah Screening — 5 Standards

Based on financial data from December 2025

Standard Debt Ratio Cash Ratio Receivables Income Status
AAOIFI 4.9%
/ 30%
11.2%
/ 30%
4.5%
/ 30%
0.84%
/ 5%
✓ HALAL
DJIM 4.9%
/ 33%
11.2%
/ 33%
4.5%
/ 33%
0.84%
/ 5%
✓ HALAL
MSCI 11.2%
/ 33%
25.6%
/ 33%
10.2%
/ 33%
0.84%
/ 5%
✓ HALAL
S&P 4.9%
/ 33%
11.2%
/ 33%
4.5%
/ 33%
0.84%
/ 5%
✓ HALAL
FTSE 11.2%
/ 33%
25.6%
/ 33%
10.2%
/ 50%
0.84%
/ 5%
✓ HALAL

Financial Highlights

EPS
$-0.24
P/B Ratio
2.9
EV/EBITDA
121.6
EV: $1.3B
Revenue
$535M
Growth: 13.1%
Beta
1.4
High volatility
Current Ratio
4.0

Profitability

Gross Margin 75.0%
Operating Margin 1.8%
Net Margin -2.1%
Return on Equity (ROE) -2.4%
Return on Assets (ROA) -0.9%

Cash Flow & Balance Sheet

Operating Cash Flow$57M
Free Cash Flow$42M
Total Debt$73M
Debt-to-Equity15.5
Current Ratio4.0
Total Assets$654M

Price & Trading

Last Close$30.04
50-Day MA$33.33
200-Day MA$34.98
Avg Volume656K
Beta1.4
52-Week Range
$28.29
$43.18

About AtriCure, Inc. (ATRC)

CEO
Mr. Michael H. Carrel
Employees
1,350
Sector
Healthcare
Industry
Medical Instruments & Supplies
Country
United States
Exchange
NASDAQ
Market Cap
$1.4B
Currency
USD

AtriCure, Inc. engages in the development, manufacture, and sale of devices for surgical ablation of cardiac tissue, exclusion of the left atrial appendage, and temporarily blocking pain by ablating peripheral nerves to medical centers in the United States, the Asia-Pacific, and internationally. It offers Isolator Synergy Ablation System clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation devices, a single-use disposable RF products for the treatment of cardiac arrhythmias; cryoICE Cryoablation System that enables the user to make linear ablations of varied lengths; and EPi-Sense Systems, a single-use disposable device used for the treatment of symptomatic, drug-refractory, and long-standing persistent atrial fibrillation. It also provides cryoSPHERE probe, which provides temporary pain relief by applying cryothermic energy to targeted intercoastal peripheral nerves in the ribcage; AtriClip System, an implantable device coupled to a single-use disposable applier; cryoXT probes, a cryoablation device designed specifically for Cryo Nerve Block therapy; LARIAT System, a solution for soft-tissue closure; Lumitip dissectors to separate tissues to provide access to key anatomical structures that are targeted for ablation; Glidepath guides for placement of clamps; and Subtle Cannula's to support access for EPi-Sense catheters. In addition, the company sells various reusable cardiac surgery instruments. It markets and sells its products through independent distributors and direct sales personnel. The company was incorporated in 2000 and is headquartered in Mason, Ohio.

Purification Calculator

As a halal stock with 0.84% impermissible income, you need to purify your dividends.

Enter your dividends to calculate purification amount

Related Halal Stocks in Healthcare

Frequently Asked Questions

Is AtriCure, Inc. (ATRC) halal to invest in?

Based on our screening using AAOIFI Standard 21 (the strictest methodology), AtriCure, Inc. is Halal. The company passes all financial ratio thresholds for debt, cash, receivables, and impermissible income. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.

What is AtriCure, Inc.'s debt ratio?

AtriCure, Inc.'s debt ratio is 4.9% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 11.2%.

Does AtriCure, Inc. require dividend purification?

Yes, AtriCure, Inc. has an impermissible income ratio of 0.84%, which means 0.84% of any dividends received should be donated to charity as purification. This is because a small portion of the company's revenue comes from non-Shariah-compliant sources.

What are AtriCure, Inc.'s key financial metrics?

AtriCure, Inc. has a market capitalization of $1.4B, and revenue of $535M. The company maintains a gross margin of 75.0% and a net margin of -2.1%. Return on equity stands at -2.4%.

How often is the screening data updated?

Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.

Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.